Last updated on April 2013

A Randomized, Double-Blinded, Placebo-Controlled Multiple Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BIIB037 in Subjects With Prodromal or Mild Alzheimer's Disease


Brief description of study

A Randomized, Double-Blinded, Placebo-Controlled Multiple Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BIIB037 in Subjects With Prodromal or Mild Alzheimer's Disease

Detailed Study Description

Patient Inclusion Criteria:

  • Ages: over 55-90
  • Male/Female
  • 12 Month Long Clinical Trial
  • MMSE score 24-30/20-26
  • Subjects must meet criteria for Prodromal AD or Mild AD:
    • Mini Mental State Examination (MMSE) score between 20-30
    • Clinical Dementia Rating Scale (CDR) score of 0.5 or 1
    • a free recall score of lesser or equal to 27 on the Free and Cued Selective Reminding Test (FCSRT) for prodromal AD.
  • Subjects must have a positive florbetapir PET amyloid scan.
  • Subjects must consent to APOE genotyping.

Patient Exclusion Criteria:

  • Any medical or neurological condition (other than AD) that might be a contributing cause of the subject's cognitive impairment.
  • Have had a stroke or TIA or unexplained loss of consciousness in the past 1 year.
  • Clinically significant psychatric illness in past 6 months.
  • Seizure in the past 3 years.
  • Have human immunodeficiency virus (HIV) infection.
  • Have a significant systematic illness or infection in past 30 days.
  • Brain MRI showing evidence of greater than 4 microhemorrhages.
  • Alcohol or substance abuse in past 1 year.
  • Taking blood thinners (except for aspirin up to 325mg daily)
  • Have changes in medications or doses of medication in past 4 weeks.

Clinical Study Identifier: TX136830

Find a site near you

Start Over

Axiom Clinical Research of Florida

2919 Swann Ave, Suite 105A Tampa, FL USA
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.